Zum Inhalt

Journal of Clinical Immunology

Ausgabe 4/2024

Inhalt (21 Artikel)

Proteasome-Associated Syndromes: Updates on Genetics, Clinical Manifestations, Pathogenesis, and Treatment

  • Review

Jiahui Zhang, Panfeng Tao, Natalie T. Deuitch, Xiaomin Yu, Ivona Askentijevich, Qing Zhou

Mendelian Causes of Autoimmunity: the Lupus Phenotype

  • Review

Maud Tusseau, Samira Khaldi-Plassart, Jade Cognard, Sebastien Viel, Liliane Khoryati, Sarah Benezech, Anne-Laure Mathieu, Fréderic Rieux-Laucat, Brigitte Bader-Meunier, Alexandre Belot

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report

  • Open Access
  • Original Article

John McDonnell, Kimberley Cousins, M. Elizabeth M. Younger, Adam Lane, Hassan Abolhassani, Roshini S. Abraham, Salem Al-Tamemi, Juan Carlos Aldave-Becerra, Eman Hesham Al-Faris, Alberto Alfaro-Murillo, Suzan A. AlKhater, Nouf Alsaati, Alexa Michelle Altman Doss, Melissa Anderson, Ernestina Angarola, Barbara Ariue, Danielle E. Arnold, Amal H. Assa’ad, Caner Aytekin, Meaghan Bank, Jenna R. E. Bergerson, Jack Bleesing, John Boesing, Carolina Bouso, Nicholas Brodszki, Diana Cabanillas, Carol Cady, Meghan A. Callahan, Roberta Caorsi, Javier Carbone, Maria Carrabba, Riccardo Castagnoli, Jason R. Catanzaro, Samantha Chan, Sharat Chandra, Hugo Chapdelaine, Zahra Chavoshzadeh, Hey Jin Chong, Lori Connors, Filippo Consonni, Oscar Correa-Jimenez, Charlotte Cunningham-Rundles, Katherine D’Astous-Gauthier, Ottavia Maria Delmonte, Yesim Yilmaz Demirdag, Deepti R. Deshpande, Natalie M. Diaz-Cabrera, Victoria R. Dimitriades, Rasha El-Owaidy, Gehad ElGhazali, Suleiman Al-Hammadi, Giovanna Fabio, Astrid Schellnast Faure, Jin Feng, James M. Fernandez, Lauren Fill, Guacira R. Franco, Robert W. Frenck, Ramsay L. Fuleihan, Giuliana Giardino, Jessica Galant-Swafford, Eleonora Gambineri, Elizabeth K. Garabedian, Ashley V. Geerlinks, Ekaterini Goudouris, Octavio Grecco, Qiang Pan-Hammarström, Hedieh Haji Khodaverdi Khani, Lennart Hammarström, Nicholas L. Hartog, Jennifer Heimall, Gabriela Hernandez-Molina, Caroline C. Horner, Robert W. Hostoffer, Nataliya Hristova, Kuang-Chih Hsiao, Gabriela Ivankovich-Escoto, Faris Jaber, Maaz Jalil, Mahnaz Jamee, Tiffany Jean, Stephanie Jeong, Devi Jhaveri, Michael B. Jordan, Avni Y. Joshi, Amanpreet Kalkat, Henry J. Kanarek, Erinn S. Kellner, Amer Khojah, Ruby Khoury, Cristina M. Kokron, Ashish Kumar, Kelsey Lecerf, Heather K. Lehman, Jennifer W. Leiding, Harry Lesmana, Xin Rong Lim, Joao Pedro Lopes, Ana Laura López, Lucia Tarquini, Ingrid S. Lundgren, Julieann Magnusson, Ana Karolina B. B. Marinho, Gian Luigi Marseglia, Giulia M. Martone, Annamaria G. Mechtler, Leonardo Mendonca, Joshua D. Milner, Peter J. Mustillo, Asal Gharib Naderi, Samuele Naviglio, Jeremy Nell, Hana B. Niebur, Luigi Notarangelo, Matias Oleastro, María Claudia Ortega-López, Neil R. Patel, Gordana Petrovic, Claudio Pignata, Oscar Porras, Benjamin T. Prince, Jennifer M. Puck, Nashmia Qamar, Marco Rabusin, Nikita Raje, Lorena Regairaz, Kimberly A. Risma, Elizabeth H. Ristagno, John Routes, Persio Roxo-Junior, Negin Salemi, Christopher Scalchunes, Susan J. Schuval, Suranjith L. Seneviratne, Ashwin Shankar, Roya Sherkat, Junghee Jenny Shin, Abeer Siddiqi, Sara Signa, Ali Sobh, Fabiana Mascarenhas Souza Lima, Kristen K. Stenehjem, Jonathan S. Tam, Monica Tang, Myrthes Toledo Barros, James Verbsky, Eleni Vergadi, Dayne H. Voelker, Stefano Volpi, Luke A. Wall, Christine Wang, Kelli W. Williams, Eveline Y. Wu, Shan Shan Wu, Jessie J. Zhou, Alexandria Cook, Kathleen E. Sullivan, Rebecca Marsh

Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients

  • Open Access
  • Original Article

Ami Aoki, Chiaki Iwamura, Masahiro Kiuchi, Kaori Tsuji, Atsushi Sasaki, Takahisa Hishiya, Rui Hirasawa, Kota Kokubo, Sachiko Kuriyama, Atsushi Onodera, Tadanaga Shimada, Tetsutaro Nagaoka, Satoru Ishikawa, Akira Kojima, Haruki Mito, Ryota Hase, Yasunori Kasahara, Naohide Kuriyama, Sukeyuki Nakamura, Takashi Urushibara, Satoru Kaneda, Seiichiro Sakao, Osamu Nishida, Kazuhisa Takahashi, Motoko Y. Kimura, Shinichiro Motohashi, Hidetoshi Igari, Yuzuru Ikehara, Hiroshi Nakajima, Takuji Suzuki, Hideki Hanaoka, Taka-aki Nakada, Toshiaki Kikuchi, Toshinori Nakayama, Koutaro Yokote, Kiyoshi Hirahara

A deep intronic BTK variant underlies X-linked agammaglobulinemia

  • Correspondence

Shoichiro Tateishi, Shoichi Shimizu, Kunihiko Moriya, Hirokazu Kanegane, Kohsuke Imai

OTULIN Haploinsufficiency Causes Hyperinflammatory Responses to Infectious and Non-Infectious Triggers

  • Correspondence

Laura Batlle-Masó, Maria Antolin, Joana Marques-Soares, Romina Dieli-Crimi, Roger Colobran

An Indian Family with Autosomal Dominant Hyper-IgE Syndrome Due to IL6ST Defect

  • Letter to Editor

Suprit Basu, Shubham Goel, Amit Rawat, Pandiarajan Vignesh, Biman Saikia

Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine

  • Letter to Editor

Lorne Schweitzer, Sapha Barkati, Pierre Laneuville, Susan Fox, Donald C. Vinh

Severe Herpes Simplex Encephalitis: an Unusual Presentation of IPEX

  • Letter to Editor

Linda Rossini, Claudia Maria Bonardi, Silvia Bresolin, Eva Trevisson, Antonio Marzollo

Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion

  • Open Access
  • Original Article

Ibrahim Serhat Karakus, Mehmet Cihangir Catak, Alexandra Frohne, Feyza Bayram Catak, Melek Yorgun Altunbas, Royala Babayeva, Sevgi Kostel Bal, Sevgi Bilgic Eltan, Ezgi Yalcin Gungoren, Fehim Esen, Itir Ebru Zemheri, Elif Karakoc-Aydiner, Ahmet Ozen, Suar Caki-Kilic, Michael J. Kraakman, Kaan Boztug, Safa Baris

Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF

  • Open Access
  • Original Article

June-Young Koh, Doo Ri Kim, Sohee Son, Hwanhee Park, Kyung-Ran Kim, Sunwoo Min, Ha Seok Lee, Byung Woo Jhun, Eun-Suk Kang, Inkyung Jung, Ji-Man Kang, Yae-Jean Kim, Eui-Cheol Shin

Novel Synonymous Variant in IL7R Causes Preferential Expression of the Soluble Isoform

  • Open Access
  • Original Article

Rafah Mackeh, Yasmin El Bsat, Asha Elmi, Hani Bibawi, Mohammed Yousuf Karim, Amel Hassan, Bernice Lo

Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib

  • Open Access
  • Research

Laura Dotta, Francesca Todaro, Manuela Baronio, Mauro Giacomelli, Marinella Pinelli, Martina Giambarda, Beatrice Brognoli, Silvia Greco, Francesca Rota, Manuela Cortesi, Annarosa Soresina, Daniele Moratto, Cesare Tomasi, Rosalba Monica Ferraro, Silvia Giliani, Raffaele Badolato

Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns

  • Research

Andrey V. Marakhonov, Irina Yu. Efimova, Anna A. Mukhina, Rena A. Zinchenko, Natalya V. Balinova, Yulia Rodina, Dmitry Pershin, Oxana P. Ryzhkova, Anna A. Orlova, Viktoriia V. Zabnenkova, Tatiana B. Cherevatova, Tatiana S. Beskorovainaya, Olga A. Shchagina, Alexander V. Polyakov, Zhanna G. Markova, Marina E. Minzhenkova, Nadezhda V. Shilova, Sergey S. Larin, Maryam B. Khadzhieva, Ekaterina S. Dudina, Ekaterina V. Kalinina, Dzhaina A. Mudaeva, Djamila H. Saydaeva, Svetlana A. Matulevich, Elena Yu. Belyashova, Grigoriy I. Yakubovskiy, Inna S. Tebieva, Yulia V. Gabisova, Nataliya A. Irinina, Liya R. Nurgalieva, Elena V. Saifullina, Tatiana I. Belyaeva, Olga S. Romanova, Sergey V. Voronin, Anna Shcherbina, Sergey I. Kutsev

Analysis of Clinical, Immunological and Molecular Features of Leukocyte Adhesion Deficiency Type I in Egyptian Children

  • Open Access
  • Research

Mai Magdy Saad, Radwa Alkady, Alia Eldash, Rabab E. El Hawary, Safa S. Meshaal, Nermeen M. Galal, Aisha M. Elmarsafy

22q11.2 Deletion-Associated Blood-Brain Barrier Permeability Potentiates Systemic Capillary Leak Syndrome Neurologic Features

  • Research

Alexis M. Crockett, Hania Kebir, Stewart A. Anderson, Soma Jyonouchi, Neil Romberg, Jorge I. Alvarez

Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3

  • Open Access
  • Research

Christo Tsilifis, Jarmila Stremenova Spegarova, Ross Good, Helen Griffin, Karin R. Engelhardt, Sophie Graham, Stephen Hughes, Peter D. Arkwright, Sophie Hambleton, Andrew R. Gennery

Inborn Errors of Immunity in Jordan: First Report from a Tertiary Referral Center

  • Research

Raed Alzyoud, Motasem Alsuweiti, Heba Maaitah, Boshra Aladaileh, Mohammed Noubani, Hamazh Nsour

Phenotypic and Immunological Characterization of Patients with Activated PI3Kδ Syndrome 1 Presenting with Autoimmunity

  • Open Access
  • Research

Qifan Li, Wenjie Wang, Qi Wu, Qinhua Zhou, Wenjing Ying, Xiaoying Hui, Bijun Sun, Jia Hou, Feng Qian, Xiaochuan Wang, Jinqiao Sun

Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis

  • Research

Takako Suzuki, Yoshitaka Sato, Yusuke Okuno, Yuka Torii, Yuto Fukuda, Kazunori Haruta, Makoto Yamaguchi, Yoshiki Kawamura, Asahito Hama, Atsushi Narita, Hideki Muramatsu, Tetsushi Yoshikawa, Yoshiyuki Takahashi, Hiroshi Kimura, Yoshinori Ito, Jun-ichi Kawada

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Angiogenesehemmer mit arteriellen Komplikationen assoziiert?

Der Wirkmechanismus von Angiogeneseinhibitoren kann potenziell nicht nur Tumoren, sondern auch Arterienwänden schaden. Geht also der Einsatz der Präparate mit arteriellen Dissektionen und Aneurysmen einher? Ein französisches Studienteam gibt Entwarnung.

ES-SCLC: Tageszeit bei der PD-L1-Inhibitoren-Gabe berücksichtigen

  • 12.12.2025
  • SCLC
  • Nachrichten

In einer Studie aus China kommen die Forschenden zu dem Schluss, dass der Zeitpunkt der Infusion von PD-L1-Inhibitoren bei fortgeschrittenem kleinzelligem Lungenkarzinom mit der Überlebenszeit korreliert. Eine frühe Gabe erwies sich als vorteilhaft.

Radiotherapie bei Kopf-Hals-Tumoren möglichst nicht pausieren!

Bei Menschen mit Kopf-Hals-Karzinomen, die eine Strahlentherapie erhalten, sind längere Therapieunterbrechungen riskant, mit deutlichen Einbußen bei Rezidivfreiheit und Überleben. Das gilt laut einer US-Studie vor allem für lokal fortgeschrittene Tumoren.

Uterusmyome sind mit Atherosklerose assoziiert

Frauen mit Uterusmyomen tragen ein höheres Risiko, atherosklerotische Komplikationen zu entwickeln, wie eine große populationsbasierte Kohortenstudie ans Licht gebracht hat.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Älterer Mann erhält eine Infusion/© (M) Mathias Ernert, NCT Heidelberg (Symbolbild mit Fotomodellen), Radiotherapie einer jungen Patientin/© Valerii / stock.adobe.com (Symbolbild mit Fotomodell)